Dutch Parliament Backs Primate Research, Citing Alzheimer’s Concerns
The Dutch Parliament is resisting calls for a ban on ape research, a move that could impact studies into diseases like Alzheimer’s, AIDS, and post-COVID conditions. The decision, made on Tuesday, March 24, 2026, comes as lawmakers weigh the ethical considerations of animal testing against the potential for medical breakthroughs. This debate highlights the ongoing tension between animal welfare and the advancement of critical medical research.
The controversy centers around a proposal by the Party for the Animals to mandate that research funding be allocated specifically to non-animal testing methods. Though, a VVD amendment to block this plan gained support from D66, CDA, FvD, and BBB, suggesting a near-majority in Parliament opposes the mandated funding shift. The Biomedical Primate Research Centre (BPRC) in Rijswijk is at the heart of the discussion, as it utilizes apes in research related to serious illnesses.
While the Party for the Animals argues that prioritizing funding for alternative techniques will accelerate the transition away from animal testing, critics warn that such a measure could hinder crucial research and even lead to inbreeding issues within ape colonies. The Ministry of VWS previously cautioned that eliminating animal testing altogether could compromise the quality of medical research.
Queeny Rajkowski, the VVD representative who introduced the amendment, emphasized the importance of flexibility in research funding. “Alternatives are important but are not always sufficient, especially when dealing with complex immune responses and neurological conditions,” she stated. Caroline van der Plas, a BBB member of Parliament, echoed these concerns, warning that research into diseases like cancer and Alzheimer’s could be jeopardized.
The current government, led by Minister Letschert, is still reviewing the proposal, indicating that the political debate is ongoing. The outcome of this discussion will likely shape the future of animal research in the Netherlands and could have implications for the development of treatments for debilitating diseases.
Recent developments also show broader support for reducing animal testing. According to the Partij voor de Dieren, the Second Chamber previously approved a proposal to phase out subsidies for ape research at the BPRC, redirecting the 12.5 million euro annual funding towards the development of alternatives, with a complete cessation of government funding by 2030.
However, university medical centers and the Dutch Academy of Sciences have expressed concerns that this timeline is too aggressive, potentially hindering the testing of new medications and impacting public health. The BPRC director, Merel Langelaar, warned that a reduction in funding could lead to the center’s closure within five years. The Party for the Animals estimates that approximately 200 apes undergo experimental procedures annually at the BPRC.
